(0.02%) 5 309.09 points
(0.04%) 39 821 points
(-0.06%) 16 784 points
(-1.13%) $78.90
(-1.27%) $2.72
(-0.47%) $2 427.10
(-1.04%) $32.09
(-0.24%) $1 061.10
(0.07%) $0.921
(-0.28%) $10.67
(-0.01%) $0.787
(-0.38%) $90.34
0.98% $ 5.13
Live Chart Being Loaded With Signals
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder...
Stats | |
---|---|
Dzisiejszy wolumen | 383.00 |
Średni wolumen | 4 520.00 |
Kapitalizacja rynkowa | 66.76M |
EPS | $0 ( 2024-01-26 ) |
Last Dividend | $0.220 ( 2018-02-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | -11.40 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2018-02-28 | Anschutz Philip F | Sell | 12 440 000 | CLASS A COMMON STOCK |
2018-02-28 | Anschutz Philip F | Sell | 23 708 639 | CLASS B COMMON STOCK |
2018-02-28 | Campbell Michael L | Sell | 703 660 | Class A Common Stock |
2018-02-28 | Yemenidjian Alex | Sell | 21 880 | Class A Common Stock |
2018-02-28 | Tyrrell Jack | Sell | 136 684 | Class A Common Stock |
INSIDER POWER |
---|
0.00 |
Last 97 transactions |
Buy: 583 544 | Sell: 71 137 085 |
Regencell Bioscience Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
QNRX | 0.939 |
RGF | 0.934 |
TCPC | 0.932 |
ACAD | 0.928 |
BNRG | 0.926 |
AGRX | 0.924 |
CNXC | 0.922 |
BCAN | 0.922 |
RRGB | 0.919 |
IRDM | 0.916 |
10 Najbardziej negatywne korelacje | |
---|---|
ROAD | -0.958 |
PVAL | -0.947 |
EQRR | -0.944 |
IUS | -0.941 |
DVLU | -0.939 |
RNA | -0.937 |
MNMD | -0.936 |
CPRT | -0.935 |
ALLT | -0.935 |
AIRG | -0.934 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Regencell Bioscience Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-769 687 (0.00 %) |
EPS: | $-0.450 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-769 687 (0.00 %) |
EPS: | $-0.450 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-604 397 (0.00 %) |
EPS: | $-0.570 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.107 |
Financial Reports:
No articles found.
Regencell Bioscience Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.180 | 2009-06-02 |
Last Dividend | $0.220 | 2018-02-15 |
Next Dividend | $0 | N/A |
Payout Date | 2018-02-26 | |
Next Payout Date | N/A | |
# dividends | 36 | -- |
Total Paid Out | $7.52 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
Unable to generate commentary due to missing data.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
OXLC | Dividend Diamond | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend Royal | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | -0.465 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.455 | 1.500 | -6.17 | -9.25 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 19.15 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 19.15 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.58 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0367 | -1.500 | 9.39 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.118 | 2.00 | 9.96 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.118 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0385 | -1.500 | 9.85 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.32 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.66 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -11.21 | 1.000 | -1.234 | 0 | [1 - 100] |
returnOnEquityTTM | -0.455 | 2.50 | -3.96 | -9.25 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.118 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.118 | 2.00 | 9.96 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.254 | 1.500 | -5.03 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | -0.119 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Regencell Bioscience
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej